Sari Fishman
Corporate Officer/Principal at CAN-FITE BIOPHARMA LTD.
Net worth: - $ as of 31/03/2024
Profile
Sari Fishman is a professional with a background in business development and clinical affairs.
She is currently working as the Vice President of Business Development at Can-Fite BioPharma Ltd.
She started this position in 2017.
Previously, she worked as the Director of Clinical Affairs at OphthaliX, Inc. Dr. Fishman holds a doctorate degree from Bar-Ilan University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CAN-FITE BIOPHARMA LTD.
-.--% | 28/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Sari Fishman active positions
| Companies | Position | Start |
|---|---|---|
| CAN-FITE BIOPHARMA LTD. | Corporate Officer/Principal | 01/01/2014 |
Former positions of Sari Fishman
| Companies | Position | End |
|---|---|---|
OphthaliX, Inc.
 OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Chief Tech/Sci/R&D Officer | - |
Training of Sari Fishman
| Bar-Ilan University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CAN-FITE BIOPHARMA LTD. | Health Technology |
| Private companies | 1 |
|---|---|
OphthaliX, Inc.
OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Health Technology |
- Stock Market
- Insiders
- Sari Fishman
